PAVmed (PAVM) Non-Current Debt (2017 - 2026)

PAVmed (PAVM) posted Non-Current Debt of $15.1 million for Q2 2026, down 25.32% on a QoQ basis from $20.2 million in Q3 2020.

Analysis

PAVmed (PAVM) Non-Current Debt (2017 - 2026) Analysis & Trends

PAVmed has reported Non-Current Debt for 5 years, with the latest figure at $15.1 million in Q2 2026.

On a quarterly basis, Non-Current Debt changed N/A year-over-year to $15.1 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a N/A change from a year earlier, with the FY2019 full-year figure at $8.1 million, changed N/A from the prior year.
Non-Current Debt was $15.1 million for Q2 2026 at PAVmed, down from $20.2 million in the prior quarter.
The five-year high for Non-Current Debt was $15.1 million in Q2 2026, with the low at $15.1 million in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	GE HealthCare Technologies	29.54 Bn	27.44 Bn	2.18 Bn	10.09 Bn
2	Lantheus Holdings	6.56 Bn	5.97 Bn	241.86 Mn	570.35 Mn
3	Heartflow	4.04 Bn	3.66 Bn	53.19 Mn	-
4	Neogen	2.59 Bn	2.41 Bn	107.80 Mn	793.70 Mn
5	Butterfly Network	1.96 Bn	1.84 Bn	23.29 Mn	-
6	Ceribell	928.74 Mn	799.48 Mn	25.94 Mn	19.98 Mn
7	QuidelOrtho	866.04 Mn	742.64 Mn	-	2.54 Bn
8	Varex Imaging	779.06 Mn	679.86 Mn	76.70 Mn	347.10 Mn
9	Prenetics Global	339.99 Mn	280.94 Mn	30.20 Mn	-
10	PAVmed	28.84 Mn	25.06 Mn	-89,000.00	15.10 Mn

Historic Data

Download Data